• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于GRACE评分的非ST段抬高型心肌梗死患者介入治疗时间与临床结局的相关性

The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score.

作者信息

Wang Ji-Xiang, Gao Jing, Xiao Jian-Yong, Gao Ming-Dong, Zhang Nan, Lu Peng-Ju, Liu Yin

机构信息

Cardiology Institute, Tianjin Chest Hospital, Tianjin 300222, China.

Institute of Cardiovascular Diseases, Tianjin Chest Hospital, Tianjin 300222, China.

出版信息

Appl Bionics Biomech. 2022 Apr 29;2022:7614619. doi: 10.1155/2022/7614619. eCollection 2022.

DOI:10.1155/2022/7614619
PMID:35528530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9076324/
Abstract

OBJECTIVE

To investigate the relevance between interventional time and clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients of different risk stratifications, which were divided into different groups according to GRACE scores and the time from admission to percutaneous coronary intervention (PCI).

METHOD

Patients were grouped according to the GRACE score and the time from admission to intervention therapy. The Cox multivariate risk regression model was used to analyze the correlation between the GRACE score and the time from admission to intervention therapy with major adverse cardiovascular events (MACEs). Cox interactive item regression was also used to investigate the correlation between the time of intervention therapy and GRACE risk stratification with clinical outcomes and to evaluate the efficacy of intervention therapy in different risk stratifications of patients with NSTEMI.

RESULTS

Interactive item Cox regression analysis and subgroup analysis show that high-risk NSTEMI patients with a GRACE score > 140 points and the time from admission to intervention < 24 h ( = 0.0004) and 24-72 h ( = 0.0143) have interactive effects on the impact of the MACE event with the reference of intervention time > 72 h and GRACE score < 108 points. The time from admission to intervention < 24 h is an independent protective factor for the occurrence of MACE events (HR = 0.166, 95% CI 0.052-0.532, = 0.0025). Middle-risk patients with NSTEMI with a GRACE score of 109-140 points and the time from admission to intervention < 24 h ( = 0.0370) and 24-72 h ( = 0.0471) have an interactive effect on the impact of MACE. The time from admission to intervention > 72 h is an independent protective factor for the occurrence of MACE (HR = 0.201, 95% CI 0.045-0.897, = 0.0355).

CONCLUSION

The time from admission to intervention < 24 h could effectively reduce the risk of MACE events within 1 year in high-risk patients with NSTEMI (GRACE score > 140 points); the time from admission to intervention > 72 h can reduce the risk of MACE events within 1 year in low-risk patients with NSTEMI (GRACE score ≤ 108 points).

摘要

目的

探讨不同危险分层的非ST段抬高型心肌梗死(NSTEMI)患者介入时间与临床结局之间的相关性,这些患者根据全球急性冠状动脉事件注册(GRACE)评分以及从入院到经皮冠状动脉介入治疗(PCI)的时间分为不同组。

方法

根据GRACE评分和从入院到介入治疗的时间对患者进行分组。采用Cox多因素风险回归模型分析GRACE评分和从入院到介入治疗的时间与主要不良心血管事件(MACE)之间的相关性。还采用Cox交互项回归分析介入治疗时间与GRACE危险分层与临床结局之间的相关性,并评估介入治疗在不同危险分层的NSTEMI患者中的疗效。

结果

交互项Cox回归分析和亚组分析显示,GRACE评分>140分且从入院到介入时间<24小时(P = 0.0004)和24 - 72小时(P = 0.0143)的高危NSTEMI患者,以介入时间>72小时且GRACE评分<108分为参照,对MACE事件的影响存在交互作用。从入院到介入时间<24小时是MACE事件发生的独立保护因素(HR = 0.166,95%CI 0.052 - 0.532,P = 0.0025)。GRACE评分为109 - 140分且从入院到介入时间<24小时(P = 0.0370)和24 - 72小时(P = 0.0471)的中危NSTEMI患者对MACE的影响存在交互作用。从入院到介入时间>72小时是MACE发生的独立保护因素(HR = 0.201,95%CI 0.045 - 0.897,P = 0.0355)。

结论

从入院到介入时间<24小时可有效降低高危NSTEMI患者(GRACE评分>140分)1年内发生MACE事件的风险;从入院到介入时间>72小时可降低低危NSTEMI患者(GRACE评分≤108分)1年内发生MACE事件的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7237/9076324/9cbc5949eebf/ABB2022-7614619.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7237/9076324/18fedb7a5f14/ABB2022-7614619.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7237/9076324/b03d343611f7/ABB2022-7614619.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7237/9076324/9cbc5949eebf/ABB2022-7614619.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7237/9076324/18fedb7a5f14/ABB2022-7614619.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7237/9076324/b03d343611f7/ABB2022-7614619.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7237/9076324/9cbc5949eebf/ABB2022-7614619.003.jpg

相似文献

1
The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score.基于GRACE评分的非ST段抬高型心肌梗死患者介入治疗时间与临床结局的相关性
Appl Bionics Biomech. 2022 Apr 29;2022:7614619. doi: 10.1155/2022/7614619. eCollection 2022.
2
Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.三种基于炎症的格拉斯哥预后评分对急性心肌梗死患者住院期间主要心血管不良事件的预测价值:一项回顾性研究
PeerJ. 2020 Apr 24;8:e9068. doi: 10.7717/peerj.9068. eCollection 2020.
3
Correlation Analysis of Plasma Myeloperoxidase Level With Global Registry of Acute Coronary Events Score and Prognosis in Patients With Acute Non-ST-Segment Elevation Myocardial Infarction.急性非ST段抬高型心肌梗死患者血浆髓过氧化物酶水平与急性冠状动脉事件全球注册评分及预后的相关性分析
Front Med (Lausanne). 2022 Mar 28;9:828174. doi: 10.3389/fmed.2022.828174. eCollection 2022.
4
Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI.N 末端脑钠肽前体与 NSTEMI 患者入院后 12 个月主要不良心脏事件的关系。
Ann Palliat Med. 2021 May;10(5):5231-5243. doi: 10.21037/apm-20-2538. Epub 2021 May 12.
5
Early coronary angiography in NSTEMI: a regional Victorian perspective.非 ST 段抬高型心肌梗死患者的早期冠状动脉造影:维多利亚地区的观点。
Intern Med J. 2024 Oct;54(10):1704-1712. doi: 10.1111/imj.16465. Epub 2024 Jul 3.
6
Optimal Timing of Invasive Coronary Angiography following NSTEMI.非 ST 段抬高型心肌梗死患者行冠状动脉介入治疗的最佳时机。
J Interv Cardiol. 2020 Mar 3;2020:8513257. doi: 10.1155/2020/8513257. eCollection 2020.
7
Prognostic value of the combination of GRACE risk score and mean platelet volume to lymphocyte count ratio in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention.GRACE风险评分与平均血小板体积与淋巴细胞计数比值联合应用对ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的预后价值
Exp Ther Med. 2020 Jun;19(6):3664-3674. doi: 10.3892/etm.2020.8626. Epub 2020 Mar 26.
8
Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome.GRACE评分和SYNTAX评分对预测非ST段抬高型急性冠状动脉综合征患者预后的价值。
World J Clin Cases. 2021 Nov 26;9(33):10143-10150. doi: 10.12998/wjcc.v9.i33.10143.
9
Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study.与单纯临床评估相比,系统使用GRACE评分系统(除临床评估外)对非ST段抬高型心肌梗死(NSTEMI)管理中缺血性结局和出血并发症的临床有效性:一项前瞻性研究。
Heart Vessels. 2016 Jun;31(6):897-906. doi: 10.1007/s00380-015-0695-8. Epub 2015 Jun 6.
10
The prognostic utility of GRACE risk score in predictive adverse cardiovascular outcomes in patients with NSTEMI and multivessel disease.GRACE 风险评分在预测非 ST 段抬高型心肌梗死伴多血管病变患者不良心血管结局中的预后价值。
BMC Cardiovasc Disord. 2022 Dec 26;22(1):568. doi: 10.1186/s12872-022-03025-6.

引用本文的文献

1
Retracted: The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score.撤回:基于GRACE评分的非ST段抬高型心肌梗死患者介入治疗时间与临床结局的相关性
Appl Bionics Biomech. 2023 Nov 1;2023:9826039. doi: 10.1155/2023/9826039. eCollection 2023.

本文引用的文献

1
Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.非 ST 段抬高型急性冠状动脉综合征患者早期与标准治疗的有创检查和治疗。
Circulation. 2018 Dec 11;138(24):2741-2750. doi: 10.1161/CIRCULATIONAHA.118.037152.
2
Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.在临床试验和现实生活中观察到的非ST段抬高型心肌梗死患者结局的不同观点。
Eur Heart J. 2018 Nov 7;39(42):3821-3824. doi: 10.1093/eurheartj/ehy610.
3
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials.
14 项 TIMI 试验纳入的 66252 例非 ST 段抬高急性冠状动脉综合征患者的死亡模式和时间。
Eur Heart J. 2018 Nov 7;39(42):3810-3820. doi: 10.1093/eurheartj/ehy556.
4
Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.罪犯动脉完全闭塞对急性非 ST 段抬高型心肌梗死的影响:系统评价和荟萃分析。
Eur Heart J. 2017 Nov 1;38(41):3082-3089. doi: 10.1093/eurheartj/ehx418.
5
Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban).高危非 ST 段抬高型心肌梗死患者行介入治疗的血管造影时机与结局:来自 TAO 试验(奥塔米星治疗急性冠状动脉综合征)的见解。
Circulation. 2017 Nov 14;136(20):1895-1907. doi: 10.1161/CIRCULATIONAHA.117.029779. Epub 2017 Sep 11.
6
Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.急性心肌梗死:FAST-MI 项目(1995 年至 2015 年法国急性 ST 段抬高或非 ST 段抬高心肌梗死注册研究)20 年来患者特征、治疗方法的变化和 6 个月预后
Circulation. 2017 Nov 14;136(20):1908-1919. doi: 10.1161/CIRCULATIONAHA.117.030798. Epub 2017 Aug 27.
7
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.非 ST 段抬高型急性冠脉综合征患者的早期侵入性与非侵入性治疗(FRISC-II):前瞻性、随机、多中心研究 15 年随访。
Lancet. 2016 Oct 15;388(10054):1903-1911. doi: 10.1016/S0140-6736(16)31276-4. Epub 2016 Aug 29.
8
Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013.2003-2013 年非 ST 段抬高型心肌梗死患者生存改善与临床因素和治疗策略的关系。
JAMA. 2016 Sep 13;316(10):1073-82. doi: 10.1001/jama.2016.10766.
9
Acute myocardial infarction.急性心肌梗死。
Lancet. 2017 Jan 14;389(10065):197-210. doi: 10.1016/S0140-6736(16)30677-8. Epub 2016 Aug 5.
10
Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.支架时代不稳定型心绞痛和非ST段抬高型心肌梗死的常规侵入性策略与选择性侵入性策略
Cochrane Database Syst Rev. 2016 May 26;2016(5):CD004815. doi: 10.1002/14651858.CD004815.pub4.